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Abstracts / International Journal of Surgery 12 (2014) S13eS117S28comparison; switching to oral analgesia (p¼0.344), removal of catheter
(p¼0.739), post op mobilisation (0.795), re-admission rate (p¼0.577) post-
operative complications, 32% vs 47 (p¼0.223) and length of hospital stay; 7
vs 8 days (p¼0.183).
Conclusions: This study supports the inclusion of older patients in ERAS
programme in elective colorectal surgery.
0528: THE INFLUENCE OF SURGICAL SPECIALISATION ON SHORT AND
LONGER-TERM SURVIVAL FOLLOWING SURGERY FOR COLON CANCER
Raymond Oliphant*,1, Gary Nicholson 1, Paul Horgan 2, Donald McMillan 1,
David Morrison 3. 1University Department of Surgery, Glasgow Royal Inﬁrmary,
Glasgow, UK; 2West of Scotland Colorectal Cancer Managed Clinical Network,
Glasgow, UK; 3West of Scotland Cancer Surveillance Unit, University of Glasgow,
Glasgow, UK.
Introduction: To examine short and longer-term outcomes after colon
cancer surgery performed by specialist colorectal surgeons compared to
non-specialists.
Methods: Patients undergoing surgery for colon cancer in 16 hospitals
from 2001-2004 were identiﬁed from a prospectively maintained regional
audit database. Patients were identiﬁed as having surgery under the care
of a specialist or non-specialist. Post-operativemortality (<30-days) and 5-
year relative survival rates were compared.
Results: A total of 2618 patientswere included, ofwhich,1724 (65.9%)were
treated by a specialist and 894 (34.2%) by a non-specialist surgeon. Patients
undergoing surgery by a specialist weremore likely to be deprived, present
electively, havemore Stage I tumours, undergo surgerywith curative intent
and have12 lymphnodes examined than those treated bya non-specialist
surgeon. Post-operative mortality was lower (7.0% vs. 11.4%; P<0.001) and
5-year relative survival was higher (65.0% vs. 52.1%; P<0.001) among those
treated by a specialist surgeon. In multivariate analysis, surgery by non-
specialists was independently associated with increased post-operative
mortality (adjusted OR 1.39 (95%CI 1.02-1.90; P¼0.036)) and poorer 5-year
relative survival (adjusted RER 1.17 (95%CI 1.01-1.36; P¼0.035)).
Conclusions: Short and longer-term survival after surgery for colon cancer
was higher in those treated by specialist colorectal surgeons compared to
non-specialists.
0534: HALO e EARLY REVIEW OF PATIENT SATISFACTION
Ruth Graham*, Joy Singh, Andrew Deans. Glangwili General Hospital,
Carmarthen, UK.
Introduction: To assess patient satisfaction following Haemorrhoidal
arterial ligation operation (HALO).
Methods: All patients who underwent HALO between November 2012 and
October 2013 in our institution were identiﬁed. Patients were asked to
complete a telephone questionnaire in January 2014 on pre-operative
symptoms, post-operative recovery and satisfaction with outcome.
Results: Of the 25 patients identiﬁed 21 (12 female, median age 52, (range
31-75)) were available to complete the questionnaire. Pre-operative
symptoms included bleeding (95%), prolapse (62%), anal pain (57%) and
pain on defaecation (57%).
Post-operatively medication included analgesia (100%), metronidazole
(62%), lactulose (81%) and rectogesic ointment (24%). One patient required
24 hours catheterisation for retention and two patients required admission
for treatment of sepsis.
All patients reported a longer than expected time to return to normal
activities, however median time was 3 weeks, (range 1-10 weeks). All
patients described improvement in symptoms and between 70-92%
described complete improvement in speciﬁc symptoms. Two patients re-
ported recurrence with one requiring a further procedure.
All patients reported improvement in quality of life (71% complete improve-
ment).100%of patientswould recommend theprocedurebut requestedmore
detailed information of post-operative symptoms and recovery.
Conclusions: HALO results in a high level of patient satisfaction. Recovery
time is longer than previously suggested.
0537: ONE-YEAR NEGATIVE APPENDICECTOMY RATE AT A DISTRICT
GENERAL HOSPITAL
Jeffrey Lim, Queenie Pang*, Roderick Alexander. Great Western Hospitals
NHS Foundation Trust, Swindon, UK.
Introduction: There is no deﬁned ‘acceptable' negative appendicectomy
rate (NAR) in the UK. Previous studies indicate a NAR to be 12-34%. Despiteadvances in radiology and predictive scoring systems, appendicitis re-
mains a clinical diagnosis but inevitably some patients will have an
entirely normal appendix removed. We sought to deﬁne and compare our
local practice.
Methods: A one year retrospective observational study was performed in
our institution on all appendectomies performed on an emergency basis.
Cases were identiﬁed with the hospital electronic theatre record system
and histopathology reports were retrieved and analysed.
Results: 390 patients were identiﬁed over a one year period. 127 patients'
appendices were found to be histopathologically normal, giving a NAR of
32.6%. Within this group, 19 patients (15%) had a re-admission within six
months to hospital. Fisher's exact test was used to compare our NAR to a
recent large published series in 2013 (p¼0.711).
Conclusions: Our negative appendicectomy rate is comparable to those
previously published however, with a higher than expected re-admission
rate (15%). Practice amongst our institutions' surgeons is to remove the
appendix should no other pathology be identiﬁable at laparoscopy or open
exploration. Re-admission rates may put this practice into question.
0566: INTRODUCTION OF A DESIGNATED ERAS NURSE STILL HAS VITAL
ROLE IN IMPROVING OUTCOMES
Junaid Khan*, Claire McCutcheon, Mark Vella, Lyndsey Chisholm,
Patrick Finn, Andrew Renwick, Susan Moug. Royal Alexandra Hospital,
Paisley, UK.
Introduction: In ERAS accelerated care pathways are delivered using a
multidisciplinary approach however the role of designated ERAS nurse has
not been analysed. The aim of this study was to compare outcomes prior to
and after introduction of ERAS nurse.
Methods: This was an observational study performed at one colorectal
unit. Initially there was no designated nurse to monitor ERAS protocols.
From June2013 a designated full time ERAS nurse was introduced. Two sets
of data were compared;
Group 1 (Pre-ERAS nurse); March-May 2013 (3months),
Group 2 (Post-ERAS nurse); June-October 2013 (5months).
Results: A total of 100 consecutive patients were analysed. Group 1; 36
patients; Group 2; 64 patients. Mean ages were: Overall; 62 (range:20-93)
years, Group 1; 66 (range:44-93) years and Group 2; 59 (20-82) years.
Median length of stay was: Overall; 8 (range3-36) days, Group 1; 9
(range3-36) days and Group 2; 8 (range3-25) days. Re-admission rate was
8% (n¼3) in Group 1 and in Group 2 it was 4.7% (n¼3). Data collection was
superior in Group 2; number of variables (9 vs 22) and fully completed data
(44% vs 98%).
Conclusions: In an established programme of ERAS, introduction of a
designated ERAS nurse has very important role, in addition to optimising
data collection it also reduces re-admission rate and potentially reduces
cost.
0571: COMPARING THE CORRELATION OF FAECAL CALPROTECTIN AND
MRI ENTEROGRAPHY IN ASSESSING DISEASE ACTIVITY IN PATIENTS
WITH SUSPECTED INFLAMMATORY BOWEL DISEASE
Anokha Oomman*, Buddika Jayathilaka, Mark Owen. Withybush General
Hospital, Haverfordwest, UK.
Introduction: To assess the diagnostic accuracy of a raised faecal calpro-
tectin by comparing it withMRI enterography ﬁndings to assess if there is a
correlation between the two in patients with known/suspected inﬂam-
matory bowel disease.
Methods: In this retrospective study we looked at consecutive patients
who had faecal calprotectin tests and MRI enterography for gastrointes-
tinal symptoms between the period of September 2011 and August 2013.
Severity of bowel wall inﬂammation was assessed by noting the presence,
degree and length of inﬂammation. We also assessed wall thickness,
transmural thickness and presence of structuring, mesenteric oedema and
ﬁstula formation. This was graded between 0 to 3 (0¼ absent, 1¼mild, 2¼
moderate, 3¼severe)
Results: In total there were 363 number of patients who had a faecal
calprotectin test, out of which only 27 patients had been investigated with
MRI enterography, 55.6% (13/27) of the patients testing positive had an
organic diagnosis on further investigation. In the patients who were
investigated with an MRI enterography 18.5% (5/27) of patients had severe
bowel inﬂammation (grade 3) which corresponded to a mean faecal cal-
protectin of >300 mg/g.
